FilingSEC EDGAR8-K
46% Increase in Product Sales for Q3 2026
· SEC accepted
StageEarnings Announcement
Filing content
ImmuCell reported a 46% increase in product sales for the third quarter of 2026, reaching $8.0 million, driven by sales team expansion and improved commercial execution.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…